[144] Standex International Corporation SEC Filing

Rhea-AI Filing Summary

Standex International Corporation (SXI) filing a Form 144 reports a proposed sale of 1,085 common shares by a person associated with the issuer. The shares are held at Fidelity Brokerage Services and the proposed approximate aggregate market value is $227,739.90 with an approximate sale date of 08/26/2025 on the NYSE. The shares were acquired by restricted stock vesting on 08/23/2025 and the payment is listed as compensation. The filer also disclosed a prior sale by the same person of 3,047 common shares on 08/06/2025 that generated gross proceeds of $584,446.61. The filer attests there is no undisclosed material adverse information and includes the standard signature and legal warnings.

Insights

Securities Analyst

TL;DR: Insiders plan a small post-vesting sale; disclosures are routine and likely not material to SXI's valuation.

The filing shows a planned sale of 1,085 shares with an aggregate value of $227,739.90 and a recent prior sale of 3,047 shares for $584,446.61. The new shares were acquired through restricted stock vesting and are being sold as compensation. This is a typical insider liquidity event following vesting and the filing includes the required attestation about material nonpublic information. Given the sizes disclosed relative to typical market capitalizations for listed companies, this appears informational and procedural rather than a signal of company distress or material corporate action.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 requirements; no governance red flags in the text provided.

The Form 144 lists the broker, share counts, acquisition date, nature of acquisition (restricted stock vesting), and indicates sale timing and exchange. It includes the standard representation that no undisclosed material adverse information exists. There is no mention of extraordinary compensation arrangements, related-party transfers, or unusual payment terms. From a governance perspective, the filing appears routine and complete for the transaction described.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1085	227739.90	12068262	08/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/23/2025	Restricted Stock Vesting	Issuer			1085	08/23/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ademir Sarcevic 23 Keewaydin Drive Salem NH 03079	Common	08/06/2025	3047	584446.61

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Standex International (SXI) report in this Form 144?

The filing reports a proposed sale of 1,085 common shares valued at approximately $227,739.90, acquired via restricted stock vesting on 08/23/2025, with an approximate sale date of 08/26/2025 on the NYSE.

Who is the broker handling the proposed sale for SXI?

The broker named is Fidelity Brokerage Services LLC located at 900 Salem Street, Smithfield, RI; the sale is listed for execution on the NYSE.

Has the filer recently sold other SXI shares?

Yes. The filing discloses a prior sale by the same person of 3,047 common shares on 08/06/2025, producing gross proceeds of $584,446.61.

How were the 1,085 shares acquired according to the filing?

The shares were acquired through restricted stock vesting on 08/23/2025, and the nature of payment is listed as compensation.

Does the filer state there is any undisclosed material information?

By signing the notice, the filer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.